All stock lists
Hartford Insurance Group, Inc. (HIG)
NYSE: HIG · Real-Time Price · USD
Financial Services · Insurance - Diversified
136.64-0.12 (-0.09%)
Insider Score
––Not scored
HIG Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
HIG analyst forecast
HIG analyst consensus
Hold7 ratings
Buy 3 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
HIG 12-month price target
No published price targets in the last 12 months.
Best analysts covering HIG
- Piper Sandler100%success rate · 12 calls
- Keefe, Bruyette & Woods100%success rate · 9 calls
- Argus Research100%success rate · 1 call
- Wells Fargo94%success rate · 16 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
HIG analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-10-12 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-10-12 |
| — | Mizuho | Neutral | — | — | Reiterated | 2026-10-07 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-10-07 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-10-06 |
| — | UBS | Buy | — | — | Reiterated | 2026-10-06 |
| — | Mizuho | Neutral | — | — | Downgraded | 2026-09-16 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-07-28 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-07-27 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-07-27 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-07-20 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2026-07-15 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2026-07-10 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-07-09 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-07-09 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-07-09 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-07-08 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-06-12 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-06-11 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-06-05 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-06-05 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-06-04 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-04-28 |
| — | UBS | Buy | — | — | Reiterated | 2026-04-27 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-24 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-04-14 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-04-09 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-04-09 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-08 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Downgraded | 2026-03-30 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2026-02-05 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-02-04 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-02-03 |
| — | UBS | Buy | — | — | Reiterated | 2026-02-02 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-02-02 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-02 |
| — | Roth Capital | Neutral | — | — | Reiterated | 2026-01-30 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-01-14 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-01-13 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-01-07 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2026-01-07 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2026-01-06 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-12-22 |
| — | UBS | Buy | — | — | Reiterated | 2025-12-08 |
| — | Argus Research | Buy | — | — | Reiterated | 2025-11-25 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-11-17 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2025-11-04 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-10-29 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-10-09 |
| — | UBS | Buy | — | — | Reiterated | 2025-10-08 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-10-08 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-10-07 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2025-10-01 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-09-02 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2025-08-04 |
| — | UBS | Buy | — | — | Reiterated | 2025-08-04 |
| — | Raymond James | Outperform | — | — | Reiterated | 2025-08-01 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-07-30 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-07-30 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-07-29 |
HIG earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-01-29 | 3.17 | 4.06 | $7.29B | $7.34B |
| 2026-04-23 | 3.39 | 3.09 | $7.35B | $7.23B |
| 2026-07-23 | 3.16 | 3.42 | $7.17B | $7.26B |
| 2026-10-26 | 3.17 | 0.00 | $7.37B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.